Skip to main content

Table 3 LASSO-penalized multivariable Cox analysis after PSM

From: Is prior cancer history a hindrance for non-small cell lung cancer patients to participate in clinical trials?

Characteristic

OS

DFS

HR

95% CI

P

HR

95% CI

P

Age, years

  

 < 0.001

  

0.001

 Continue

1.054

1.027–1.082

 

1.048

1.020–1.077

 

BMI

  

0.258

  

0.418

 Continue

0.965

0.907–1.027

 

0.972

0.908–1.041

 

Histology

  

0.013

  

0.034

 ADC

1

  

1

  

 SCC

1.509

0.912–2.498

 

1.474

0.786–2.767

 

 Other

2.597

1.329–5.076

 

2.671

1.261–5.655

 

Pathologic TNM stage

  

 < 0.001

  

0.013

 I

1

  

1

  

 II

4.005

2.260–7.097

 

2.947

1.374–6.322

 

 III

5.343

3.284–8.695

 

2.999

1.007–8.933

 

Postoperative complication

  

0.281

  

0.230

 Without

1

  

1

  

 With

1.602

0.680–3.774

 

1.734

0.706–4.529

 

Sex

     

0.009

 Male

   

1

  

 Female

   

0.455

0.253–0.818

 

Smoking

     

0.019

 Non-smoker

   

1

  

 Smoker

   

2.213

1.139–4.300

 

FEV1%

     

0.575

 Continue

   

1.004

0.991–1.017

 

DLCO%

     

0.026

 Continue

   

0.982

0.967–0.998

 

ASA grade

     

0.918

 1

   

1

  

 2

   

1.258

0.648–2.440

 

 3

   

1.108

0.352–3.485

 

 4

   

1.652

0.933–4.237

 

Surgical approach

     

0.190

 VATS

   

1

  

 Open

   

1.527

0.811–2.875

 

Tumor location

     

0.809

Right upper lobe

   

1

  

 Right middle lobe

   

0.640

0.225–1.823

 

 Right lower lobe

   

0.725

0.373–1.408

 

 Left upper lobe

   

0.781

0.450–1.356

 

 Left lower lobe

   

0.786

0.394–1.570

 

VPI

     

0.874

 Without

   

1

  

 With

   

1.042

0.625–1.738

 

LVI

     

0.271

 Without

   

1

  

 With

   

1.414

0.763–2.619

 

Pathologic N category

     

0.454

 0

   

1

  

 1

   

1.540

0.631–3.759

 

 2

   

1.823

0.603–5.512

 
  1. LASSO least absolute shrinkage and selection operator, PSM propensity score matching, OS overall survival, DFS disease-free survival, BMI body mass index, ADC adenocarcinoma, SCC squamous cell carcinoma, TNM tumor-node-metastasis, FEV1 forced expiratory volume in 1 s, DLCO diffusion capacity for carbon monoxide, ASA the American Society of Anesthesiologists, VATS video assisted thoracic surgery, VPI visceral pleural invasion, LVI lymphovascular invasion
  2. a Age, BMI, histology, pathologic TNM stage and postoperative complication were included in the multivariable Cox analysis of OS after PSM
  3. b Age, BMI, histology, pathologic TNM stage, postoperative complication, sex, smoking, FEV1%, DLCO%, ASA grade, surgical approach, tumor location, VPI, LVI and N category were included in the multivariable Cox analysis of DFS after PSM